生物导向治具有针对性强，药物用量少，副作用低，疗效高而近年来得到迅速发展并开始使用于临床。我院用转铁蛋白受体单克隆抗体（导癌灵）与表阿霉素及顺泊偶联，并联合使用干扰素对18例晚期肝癌患者进行了治疗，现分析报告如下。1临床资料1．1一般资料：治疗组为1997年1月～6 Bio-directed treatment has strong pertinence, low dosage of drugs, low side effects, and high curative effect. In recent years, it has been rapidly developed and has been used in clinical practice. In our hospital, we used the monoclonal antibody of transferrin receptor (directing cancer agent) to couple with epirubicin and cis-poise and used interferon to treat 18 patients with advanced liver cancer. The analysis report is as follows. 1 Clinical data 1.1 General information: The treatment group was from January 1997 to January 6